244 related articles for article (PubMed ID: 29957163)
1. Detection of Hepatis C Virus-Related Immunologic Markers and Their Impact on Outcomes of Living-Donor Kidney Transplant Recipients.
Denewar AA; Abbas MH; Sheashaa HA; Abdelaal I; El-Dahshan K; Matter YE; Refaie AF
Exp Clin Transplant; 2019 Feb; 17(1):79-83. PubMed ID: 29957163
[TBL] [Abstract][Full Text] [Related]
2. The Long-Term Effect of Hepatitis C Virus on the Outcome of Live-Donor Kidney Transplant Recipients. A Retrospective Study.
Denewar AA; Monem El-Hendy YA; Wafa EW; Ghorab AA; Sheashaa HA; Rashad RH; Nagib AM; Neamatallah AH; Abbas MH; Shokeir AA
Exp Clin Transplant; 2015 Oct; 13(5):402-7. PubMed ID: 26450463
[TBL] [Abstract][Full Text] [Related]
3. Effect of pretransplant hepatitis C virus on the development of new-onset diabetes mellitus after transplant in Egyptian living-donor renal allotransplant recipients at Mansoura Urology and Nephrology Center.
Abbas MH; Ismail MI; El Deeb SA; Nagib AM; Hassan NM; Refaie AF; El Maghrabi HM; Denewar AA; Bakr MA
Exp Clin Transplant; 2015 Feb; 13(1):26-34. PubMed ID: 25654411
[TBL] [Abstract][Full Text] [Related]
4. Frequency of the Original Kidney Disease and Its Effect on the Outcome of Kidney Transplant in the Urology-Nephrology Center Mansoura University.
Mashaly ME; Ismail MI; Lotfy EE; Donia AF; Wafa IW; Foda MA; Denewar AA; Abbas MH; Shokeir AA
Exp Clin Transplant; 2016 Apr; 14(2):157-65. PubMed ID: 26788876
[TBL] [Abstract][Full Text] [Related]
5. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study.
Mahmoud IM; Elhabashi AF; Elsawy E; El-Husseini AA; Sheha GE; Sobh MA
Am J Kidney Dis; 2004 Jan; 43(1):131-9. PubMed ID: 14712436
[TBL] [Abstract][Full Text] [Related]
6. Proteinuria among renal transplant patients and its relation to hepatitis C virus and graft outcome: a single center experience.
Sabry A
Exp Clin Transplant; 2010 Jun; 8(2):91-7. PubMed ID: 20565364
[TBL] [Abstract][Full Text] [Related]
7. Impact of Sex Disparities on Outcomes of Living-Donor Kidney Transplant in Egypt: Data of 979 Patients.
Matter YE; Elhadedy MA; Abbas TM; Zahab MA; Fouda MA; Refaie AF; Sheashaa HA; Abbas MH; Denewar AA; Nagib AM
Exp Clin Transplant; 2018 Apr; 16(2):133-137. PubMed ID: 28760116
[TBL] [Abstract][Full Text] [Related]
8. Impact of hepatitis C infection on renal transplant patients: a single-center experience in Libya.
Elzouki AN; Gargoum HM; Habas EM; Rayani AA; Othman M
Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1315-20. PubMed ID: 25394459
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Hepatitis C-Positive Kidney Transplant Recipients Compared With Hepatitis C-Negative Recipients in Today's Era of Immunosuppression: A UNOS Database Analysis With Long-Term Follow-Up.
Khalil A; Mujtaba MA; Aljanabi OT; Ghabril MS; Taber TE; Yaqub MS; Sharfuddin A
Exp Clin Transplant; 2017 Jun; 15(3):282-288. PubMed ID: 27310008
[TBL] [Abstract][Full Text] [Related]
10. Utilizing increased risk for disease transmission (IRD) kidneys for pediatric renal transplant recipients.
Hwang CS; Gattineni J; MacConmara M
Pediatr Nephrol; 2019 Oct; 34(10):1743-1751. PubMed ID: 31243535
[TBL] [Abstract][Full Text] [Related]
11. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
[TBL] [Abstract][Full Text] [Related]
12. Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.
La Hoz RM; Sandıkçı B; Ariyamuthu VK; Tanriover B
Am J Transplant; 2019 Nov; 19(11):3058-3070. PubMed ID: 31207073
[TBL] [Abstract][Full Text] [Related]
13. Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
Cannon RM; Locke JE; Orandi BJ; Anderson DJ; Davis EG; Mackelaite L; Dave H; Eng M; Jones CM
Transplantation; 2020 Jun; 104(6):1215-1228. PubMed ID: 31517783
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
[TBL] [Abstract][Full Text] [Related]
15. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.
Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Ensaroğlu F; Selçuk H; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():188-92. PubMed ID: 25894152
[TBL] [Abstract][Full Text] [Related]
16. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C.
Luan FL; Schaubel DE; Zhang H; Jia X; Pelletier SJ; Port FK; Magee JC; Sung RS
Transplantation; 2008 Jun; 85(11):1601-6. PubMed ID: 18551066
[TBL] [Abstract][Full Text] [Related]
17. Proteinuria after kidney transplantation: its relation to hepatitis C virus and graft outcome.
Sabry A; Hassan R; Mahmoud I; Hamed M; Sobh M
Iran J Kidney Dis; 2007 Oct; 1(2):88-97. PubMed ID: 19363283
[TBL] [Abstract][Full Text] [Related]
18. Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.
Vicari AR; Spuldaro F; Sandes-Freitas TV; Cristelli MP; Requião-Moura LR; Reusing JO; Pierrotti LC; Oliveira ML; Girão CM; Gadonski G; Kroth LV; Deboni LM; Ferreira GF; Tedesco-Silva H; Esmeraldo R; David-Neto E; Saitovitch D; Keitel E; Garcia VD; Pacheco-Silva A; Medina-Pestana JO; Manfro RC
Transpl Infect Dis; 2016 Oct; 18(5):730-740. PubMed ID: 27503081
[TBL] [Abstract][Full Text] [Related]
19. Antithymocyte Globulin Versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients With Hepatitis C Virus.
Bae S; Durand CM; Garonzik-Wang JM; Chow EKH; Kucirka LM; McAdams-DeMarco MA; Massie AB; Al Ammary F; Coresh J; Segev DL
Transplantation; 2020 Jun; 104(6):1294-1303. PubMed ID: 32433232
[TBL] [Abstract][Full Text] [Related]
20. Survival of living donor renal transplant recipients in Sri Lanka: a single-center study.
Galabada DP; Nazar AL; Ariyaratne P
Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1334-40. PubMed ID: 25394462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
